Advisor Group’s Tectonic Therapeutic TECX Stock Holding History

Advisor Group’s Portfolio TECX Stock Details TECX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1	Closed	–	–	5468
2019 Q3	$0	Buy	+1	New	+$226	﹤0.01%	5451

Other funds holding TECX

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Advisor Group's TECX Position: Q4 2019 in Review

Advisor Group sold out of Tectonic Therapeutic (TECX) in Q4 2019, closing a stake of 1 share.

Advisor Group first reported a position in TECX in Q3 2019 and held it in 1 quarter. The position peaked at $0 in Q3 2019. 89 funds tracked by Wall St. Rank hold TECX as of Q4 2019.

Advisor Group reported no remaining Tectonic Therapeutic position as of Q4 2019 after selling out during the quarter.
Advisor Group sold 1 Tectonic Therapeutic share in Q4 2019.
Advisor Group first reported a position in Tectonic Therapeutic in Q3 2019 and held it in 1 quarter.
Advisor Group's Tectonic Therapeutic position peaked at $0 in Q3 2019.
89 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.